[go: up one dir, main page]

CN114432001A - stent graft - Google Patents

stent graft Download PDF

Info

Publication number
CN114432001A
CN114432001A CN202210255550.2A CN202210255550A CN114432001A CN 114432001 A CN114432001 A CN 114432001A CN 202210255550 A CN202210255550 A CN 202210255550A CN 114432001 A CN114432001 A CN 114432001A
Authority
CN
China
Prior art keywords
stent
proximal
main body
segment
section
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202210255550.2A
Other languages
Chinese (zh)
Inventor
朱清
朱永锋
徐健伟
奚利峰
王哲恺
刘金宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Minimally Invasive Heart Pulse Medical Technology Group Co ltd
Original Assignee
Shanghai Minimally Invasive Heart Pulse Medical Technology Group Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Minimally Invasive Heart Pulse Medical Technology Group Co ltd filed Critical Shanghai Minimally Invasive Heart Pulse Medical Technology Group Co ltd
Priority to CN202210255550.2A priority Critical patent/CN114432001A/en
Publication of CN114432001A publication Critical patent/CN114432001A/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

The invention provides a covered stent, which comprises a stent body and a covering film, wherein the covering film is arranged on the surface of the stent body, the stent body comprises a main stent part and two branch stent parts, the two branch stent parts and the main stent part are fixedly connected with the covering film and form a Y-shaped structure, the stent body comprises a plurality of annular stent sections which are sequentially arranged at intervals in the axial direction, and the main stent part comprises a near-end sealing area, a main body area and a transition area which are sequentially arranged from a near end to a far end; the outer diameter of the transition region is sequentially reduced from the near end to the far end; the body regions have the same outer diameter; the outer diameter of the proximal end of the transition region is the same as the outer diameter of the main body region; the proximal sealing zone comprises a proximal sealing stent section, the transition zone comprises a transition stent section, and the body zone comprises a body stent section; the maximum length of the wave rod of the near-end sealing support section is smaller than that of the wave rod of the main body support section; so configured, improve the compliance of tectorial membrane support to reduce interior hourglass and the risk of aversion.

Description

覆膜支架stent graft

本申请是申请号为202111487656.7的分案申请。This application is a divisional application with application number 202111487656.7.

技术领域technical field

本发明属于医疗器械技术领域,特别涉及一种覆膜支架。The invention belongs to the technical field of medical devices, and particularly relates to a covered stent.

背景技术Background technique

血管介入治疗作为一种微创伤的治疗方式,为不能耐受外科手术的血管疾病患者提升了生存概率。人体血管分叉点众多,一些动脉瘤或夹层的病变区域会累及到血管分叉点及其分支。以腹主动脉为例,腹主动脉远端分叉成为两侧髂动脉。针对腹主动脉动脉瘤或夹层病例,常规的血管介入治疗手术,会在病变区域采用主体支架(置于腹主动脉病变处)和分支支架(置于双侧髂动脉病变处)在体内拼接的方式重建血流通道,尤其是病变累及到髂动脉处时,这种治疗方法更为有效。其中主体支架多数采用倒钩设计,倒钩刺破血管以进行锚定,但是这种治疗方法需要3个独立成型的支架,增加了手术成本,而且支架间的拼接也增加了拼接处内漏的风险,同时也延长了手术时间,对患者不利。目前也有极少量的一体式支架产品,但这些产品整体采用编织结构,压握尺寸大,柔顺性差,而且内漏风险高,也存在着远期移位等缺点。Vascular interventional therapy, as a minimally invasive treatment, improves the survival probability for patients with vascular disease who cannot tolerate surgery. There are many vascular bifurcation points in the human body, and some lesions of aneurysm or dissection will involve the vascular bifurcation points and their branches. Taking the abdominal aorta as an example, the distal end of the abdominal aorta bifurcates into the iliac arteries on both sides. For cases of abdominal aortic aneurysm or dissection, conventional vascular interventional surgery will use the main stent (placed at the abdominal aorta lesion) and the branch stent (placed at the bilateral iliac artery lesion) in the lesion area to splicing in vivo. This method is more effective when the iliac artery is involved in the reconstruction of blood flow. Most of the main stents are designed with barbs, and the barbs puncture the blood vessels for anchoring. However, this treatment method requires 3 independently formed stents, which increases the operation cost, and the splicing between the stents also increases the risk of endoleak at the splicing. Risk, but also prolong the operation time, which is not good for the patient. At present, there are also a very small number of integrated stent products, but these products adopt a braided structure as a whole, with large crimping size, poor flexibility, high risk of endoleak, and long-term displacement.

因此有必要提供一种新型的覆膜支架,以克服现有治疗病变区域累及到血管分叉点及分支的支架所存在的问题。Therefore, it is necessary to provide a new type of stent-graft to overcome the problems of existing stents for treating diseased areas involving vascular bifurcations and branches.

发明内容SUMMARY OF THE INVENTION

为了解决现有技术中所存在的技术问题,本发明的目的在于提供一种覆膜支架,能够改善带有分支的覆膜支架的柔顺性,还能够减小覆膜支架的压握尺寸,同时降低了内漏以及远期移位的风险。In order to solve the technical problems existing in the prior art, the purpose of the present invention is to provide a stent-graft, which can improve the flexibility of the stent-graft with branches, and can also reduce the size of the pressure-grip of the stent-graft, and at the same time The risk of endoleak and long-term displacement is reduced.

为实现上述目的及其它相关目的,本发明提供了一种覆膜支架,包括支架本体和覆膜,所述覆膜设置在所述支架本体的表面,所述支架本体包括主体支架部和分支支架部,两个所述分支支架部和一个所述主体支架部均与所述覆膜固定连接并形成Y形结构,所述支架本体包括若干轴向依次间隔排布的环形支架段;In order to achieve the above object and other related objects, the present invention provides a stent-graft, including a stent body and a membrane, the membrane is arranged on the surface of the stent body, and the stent body includes a main body support part and a branch support two of the branch support parts and one of the main body support parts are fixedly connected with the covering film and form a Y-shaped structure, and the support body includes a plurality of annular support segments arranged at intervals in the axial direction;

所述主体支架部包括从近端至远端依次排布的近端密封区、主体区和过渡区;所述主体区具有相同的外径;所述过渡区的外径由近端向远端依次减小;所述过渡区的近端的外径与所述主体区的外径相同;The main body support part includes a proximal sealing area, a main body area and a transition area arranged in sequence from the proximal end to the distal end; the main body area has the same outer diameter; the outer diameter of the transition area is from the proximal end to the distal end decrease in sequence; the outer diameter of the proximal end of the transition zone is the same as the outer diameter of the main body zone;

所述支架段包括近端密封支架段、过渡支架段、主体支架段和分支支架段;所述近端密封区包括所述近端密封支架段,所述过渡区包括所述过渡支架段,所述主体区包括所述主体支架段;The stent segment includes a proximal sealing stent segment, a transition stent segment, a main body stent segment and a branch stent segment; the proximal sealing region includes the proximal sealing stent segment, the transition region includes the transition stent segment, and the the body region includes the body support segment;

所述近端密封支架段的波杆的最大长度小于所述主体支架段的波杆的长度。The maximum length of the stem of the proximal seal stent segment is less than the length of the stem of the body stent segment.

可选的,所述覆膜支架还包括加强筋,与所述覆膜固定连接,所述加强筋沿所述主体支架部的轴向延伸设置;所述加强筋的近端设置于所述主体区上,所述加强筋的远端设置于所述过渡区的近端,所述加强筋能够限制所述主体支架部在轴向上的回缩。Optionally, the covered stent further includes a reinforcing rib, which is fixedly connected with the covering film, the reinforcing rib is arranged along the axial extension of the main body support part; the proximal end of the reinforcing rib is arranged on the main body In the area, the distal end of the reinforcing rib is disposed at the proximal end of the transition area, and the reinforcing rib can limit the axial retraction of the main body support portion.

可选的,所述加强筋的长度为所述主体区的轴向长度的1%~80%。Optionally, the length of the reinforcing rib is 1% to 80% of the axial length of the main body region.

可选的,所述加强筋的远端设置于所述过渡区的近端的第一个所述过渡支架段的波峰上,和/或,所述加强筋的近端设置于所述主体区的近端的第一个所述主体支架段上。Optionally, the distal end of the reinforcing rib is arranged on the wave crest of the first transition bracket segment at the proximal end of the transition area, and/or the proximal end of the reinforcing rib is arranged in the main body area. The proximal end of the first of the body stent segments.

可选的,所述近端密封区包括至少一个变高近端密封支架段和至少一个等高近端密封支架段;所述至少一个变高近端密封支架段和所述至少一个等高近端密封支架段在所述主体支架部的轴向上间隔排列,且在所述主体支架部的周向上对齐布置;所述至少一个变高近端密封支架段设置在所述近端密封区的最近端;所述至少一个变高近端密封支架段中的任意相邻两个矮波谷间设置至少一个高波谷。Optionally, the proximal sealing area includes at least one heightened proximal sealing stent segment and at least one equal-height proximal sealing stent segment; the at least one heightened proximal sealing stent segment and the at least one equal-height proximal sealing stent segment. The end seal bracket segments are arranged at intervals in the axial direction of the main body bracket portion, and are aligned in the circumferential direction of the main body bracket portion; the at least one raised proximal end seal bracket segment is provided on the proximal end seal region. The most proximal end; at least one high wave trough is arranged between any two adjacent low wave troughs in the at least one heightened proximal end sealing stent segment.

可选的,所述主体支架部还包括裸段,所述裸段包括一个环形支架段,所述裸段的远端与所述覆膜固定连接,所述裸段的近端轴向上伸出所述覆膜,所述裸段被配置为扩张后与血管壁贴合进行锚定,所述裸段上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。Optionally, the main body support part further includes a bare segment, the bare segment includes an annular support segment, the distal end of the bare segment is fixedly connected to the covering film, and the proximal end of the bare segment extends axially upward. After the membrane is pulled out, the bare segment is configured to adhere to the vessel wall for anchoring after expansion, and a post-release structure is provided on the bare segment for cooperating with the delivery device to realize post-release of the stent-graft.

可选的,所述裸段上设置有凹槽结构,所述凹槽结构内设置有显影部件。Optionally, a groove structure is provided on the bare segment, and a developing component is provided in the groove structure.

可选的,所述凹槽结构包括第一凹槽结构和第二凹槽结构,所述第一凹槽结构的长度大于所述第二凹槽结构的长度,所述第一凹槽结构和所述第二凹槽结构设置在所述裸段的不同的波杆上,所述第一凹槽结构的下边缘与所述第二凹槽结构的下边缘平齐,以使所述显影部件的下边缘与所述覆膜的近端边缘重合。Optionally, the groove structure includes a first groove structure and a second groove structure, the length of the first groove structure is greater than the length of the second groove structure, the first groove structure and The second groove structure is arranged on different wave rods of the bare segment, and the lower edge of the first groove structure is flush with the lower edge of the second groove structure, so that the developing component The lower edge of the membrane coincides with the proximal edge of the membrane.

可选的,所述第一凹槽结构的长度为所述第二凹槽结构的长度的1.5倍~3倍。Optionally, the length of the first groove structure is 1.5 times to 3 times the length of the second groove structure.

可选的,所述近端密封区包括一个变高近端密封支架段和至少一个等高近端密封支架段,所述一个变高近端密封支架段和最近端的所述一个等高近端密封支架段在所述主体支架部的轴向上重叠排列,且在所述主体支架部的周向上错开布置;所述至少一个变高近端密封支架段设置在所述近端密封区的最近端;所述至少一个变高近端密封支架段中的任意相邻两个矮波峰间设置至少一个高波峰。Optionally, the proximal sealing area includes a heightened proximal sealing stent segment and at least one equal-height proximal sealing stent segment, and the one heightened proximal sealing stent segment and the proximal-most equal-height proximal end. The sealing bracket segments are arranged in an overlapping manner in the axial direction of the main body bracket portion, and are arranged staggered in the circumferential direction of the main body bracket portion; the at least one heightened proximal sealing bracket segment is arranged at the nearest end of the proximal sealing region. At least one high wave crest is arranged between any two adjacent short wave crests in the at least one heightened proximal sealing stent segment.

可选的,最近端的所述一个变高近端密封支架段的高波峰的近端轴向上伸出所述覆膜形成伸出段,所述伸出段被配置为扩张后与血管壁贴合进行锚定,所述伸出段上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。Optionally, the proximal end of the high crest of the most proximal-higher proximal-end sealing stent segment extends axially from the membrane to form a protruding segment, and the protruding segment is configured to adhere to the blood vessel wall after expansion. The protruding section is provided with a post-release structure for cooperating with the delivery device to realize post-release of the stent-graft.

可选的,所述伸出段的长度为1.5mm~5.0mm。Optionally, the length of the protruding section is 1.5mm˜5.0mm.

可选的,所述主体区的横截面形状为圆形,所述过渡区的近端的横截面形状为圆形,所述过渡区的远端的横截面形状为椭圆形。Optionally, the cross-sectional shape of the main body area is circular, the cross-sectional shape of the proximal end of the transition area is circular, and the cross-sectional shape of the distal end of the transition area is elliptical.

可选的,所述覆膜支架还包括分支束缚线圈,被配置为用于绑扎同侧的分支支架部的每个支架段,同侧的分支支架部的每个支架段由至少两个所述分支束缚线圈进行绑扎。Optionally, the stent-graft further includes a branch binding coil configured to bind each stent segment of the branch stent part on the same side, and each stent segment of the branch stent part on the same side is composed of at least two said stents. Branch tying coils for tying.

在上述覆膜支架中,利用覆膜将环形支架段进行连接而形成一体式的Y形覆膜支架,这种覆膜支架大大降低了手术成本,减少了传统术式支架间的拼接所拥有的内漏的风险,同时也降低了手术时间。此外,该一体式覆膜支架在释放后主体支架部的远端“骑跨”在血管分叉点上,这种固定方式符合人体血管的自然走向,支架分叉点不会发生移位。另外,环形支架段具有更小的压握尺寸,更小的导入路径,而且环形支架段之间通过覆膜柔性连接,相比于编织结构,增加了支架的柔顺性,能更好的与人体迂曲的血管进行匹配。再者,所述主体支架部还包括过渡区,所述过渡区的外径从近端至远端逐渐减小,使其可以与覆膜贴合的更好,也更符合人体血管直径自然变化趋势,进一步减小内漏的风险。再次,所述主体支架部还包括近端密封区,所述近端密封区包括至少一个变高近端密封支架段,所述至少一个变高近端密封支架段可使支架拥有更好的近端圆整性和更大的径向支撑力,可有效地预防由支架近端与血管贴合不严造成的I型内漏,同时近端第一段变高的结构设计也可配合后释放使支架释放精准,进一步提升释放精度。In the above-mentioned stent-grafts, the annular stent segments are connected by a membrane to form an integrated Y-shaped stent-graft, which greatly reduces the operation cost and reduces the cost of splicing between traditional surgical stents. The risk of endoleak is also reduced while the operation time is reduced. In addition, the distal end of the stent graft of the main body "rides" on the bifurcation point of the blood vessel after the release, this fixing method conforms to the natural trend of human blood vessels, and the bifurcation point of the stent will not shift. In addition, the annular stent segments have a smaller crimping size and a smaller introduction path, and the annular stent segments are flexibly connected by a membrane, which increases the flexibility of the stent compared to the braided structure and can better connect with the human body. Tortuous vessels are matched. Furthermore, the main body stent part also includes a transition area, and the outer diameter of the transition area gradually decreases from the proximal end to the distal end, so that it can fit better with the covering film, and is more in line with the natural changes in the diameter of human blood vessels. trend to further reduce the risk of endoleak. Thirdly, the main body stent portion further includes a proximal sealing area, the proximal sealing area includes at least one heightened proximal sealing stent segment, and the at least one heightened proximal sealing stent segment enables the stent to have a better proximal end. End roundness and greater radial support force can effectively prevent type I endoleak caused by poor adhesion between the proximal end of the stent and the blood vessel. At the same time, the structural design of the first section of the proximal end to become higher can also be released after cooperation. Make the bracket release more precise and further improve the release accuracy.

在上述覆膜支架中,利用加强筋限制主体支架部在轴向上的回缩,在不影响支架柔顺性的情况下,有效的降低了支架近端移位的风险,使释放位置更加精准。In the above-mentioned stent-graft, reinforcing ribs are used to limit the retraction of the main body stent portion in the axial direction, which effectively reduces the risk of proximal displacement of the stent and makes the release position more accurate without affecting the flexibility of the stent.

在上述覆膜支架中,所述主体支架部还包括裸段或伸出段,裸段或伸出段上优选设置后释放结构,可与输送器匹配以实现后释放的功能。后释放可有效的减少支架释放过程中的前跳与后跳,使释放位置更加准确。同时配合“骑跨式定位”和加强筋的设置,定位效果更好,而且裸段或伸出段无需倒钩,可以既在近端锚定支架,又不损伤血管。In the above-mentioned stent-graft, the main body stent part further includes a bare segment or a protruding segment, and the bare segment or the protruding segment is preferably provided with a post-release structure, which can be matched with the conveyor to realize the post-release function. The rear release can effectively reduce the forward and backward jumps during the bracket release process, making the release position more accurate. At the same time, with the "straddle-type positioning" and the setting of reinforcing ribs, the positioning effect is better, and no barbs are required for the bare or protruding sections, which can anchor the stent at the proximal end without damaging the blood vessel.

在上述覆膜支架中,可利用分支束缚线圈如蝴蝶型线圈,对同侧的分支支架部进行绑扎,可有效避免释放时线结点被卡主导致的支架无法弹开的问题,降低了手术难度,进一步缩短了手术时间In the above-mentioned stent-grafts, branch binding coils such as butterfly coils can be used to bind the branch stent parts on the same side, which can effectively avoid the problem that the stent cannot be opened due to the wire node being stuck during release, and reduces the operation time. Difficulty, further shortening the operation time

附图说明Description of drawings

为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to these drawings without creative efforts.

图1是本发明优选实施例一的覆膜支架的结构示意图。FIG. 1 is a schematic structural diagram of a stent graft according to a preferred embodiment 1 of the present invention.

图2是本发明优选实施例一的裸段的局部结构示意图。FIG. 2 is a partial structural schematic diagram of the bare segment of the preferred embodiment 1 of the present invention.

图3是本发明优选实施例一的加强筋的结构示意图。FIG. 3 is a schematic structural diagram of a reinforcing rib according to a preferred embodiment 1 of the present invention.

图4是本发明优选实施例一的牙线绑扎主体支架部的结构示意图。FIG. 4 is a schematic structural diagram of the bracket portion of the main body of the dental floss binding according to the first preferred embodiment of the present invention.

图5是本发明优选实施例一的分支束缚线圈绑扎同侧的分支支架部的结构示意图。5 is a schematic structural diagram of a branch support portion on the same side of the branch binding coil binding in the preferred embodiment 1 of the present invention.

图6是本发明优选实施例二的覆膜支架的结构示意图。FIG. 6 is a schematic structural diagram of the stent graft according to the second preferred embodiment of the present invention.

图7a是本发明优选实施例二的变高近端密封支架段的结构示意图。Fig. 7a is a schematic structural diagram of the heightened proximal sealing stent segment according to the second preferred embodiment of the present invention.

图7b是本发明优选实施例二的等高近端密封支架段的结构示意图。Fig. 7b is a schematic structural diagram of a proximal sealing stent segment of equal height according to the second preferred embodiment of the present invention.

图7c是本发明优选实施例二的等高近端密封支架段和变高近端密封支架段在轴向上重叠且在周向上交错布置的示意图。Fig. 7c is a schematic diagram of the same-height proximal sealing stent segment and the heightened proximal sealing stent segment overlapping in the axial direction and staggered in the circumferential direction according to the second preferred embodiment of the present invention.

具体实施方式Detailed ways

为使本发明的内容更加清楚易懂,以下结合说明书附图本发明做进一步说明。当然本发明并不局限于该具体实施例,本领域的技术人员所熟知的一般替换也涵盖在本发明的保护范围内。在不冲突的情况下,下述的实施方式及实施方式中的特征可以相互补充或相互组合。In order to make the content of the present invention clearer and easier to understand, the present invention will be further described below with reference to the accompanying drawings. Of course, the present invention is not limited to this specific embodiment, and general substitutions known to those skilled in the art are also covered within the protection scope of the present invention. The following embodiments and features in the embodiments may complement each other or be combined with each other without conflict.

在本申请使用的术语是仅仅出于描述特定实施方式的目的,而非旨在限制本申请。在本申请中所使用的单数形式的“一种”、“所述”和“该”也旨在包括多数形式,除非上下文清楚地表示其他含义。应当理解,“一个”或者“一”等类似词语也不表示数量限制,而是表示存在至少一个;“多个”表示两个及两个以上的数量。“包括”或者“包含”等类似词语意指出现在“包括”或者“包含”前面的元件或者物件涵盖出现在“包括”或者“包含”后面列举的元件或者物件及其等同,并不排除其他元件或者物件。其次,本发明利用示意图进行了详细的表述,但这些示意图仅为了便于详述本发明实例,不应对此作为本发明的限定。如在本文中“近端”是指靠近心脏的一端;“远端”是指靠近操作者的一端,也即远离心脏的一端;“轴向”是指平行于轴线的方向;“径向”是指垂直于轴线的方向;“周向”是指围绕轴线的方向。如在本文中“波杆”即为支架棱,“波杆的长度”是指支架棱在其延伸方向上的尺寸。The terms used in this application are for the purpose of describing particular embodiments only and are not intended to limit the application. As used in this application, the singular forms "a," "the," and "the" are intended to include the plural forms as well, unless the context clearly dictates otherwise. It should be understood that words like "a" or "an" do not denote a quantitative limitation, but rather denote that there is at least one; "a plurality" denotes a quantity of two or more. Words like "include" or "include" mean that the elements or items appearing before "including" or "including" cover the elements or items listed after "including" or "including" and their equivalents, and do not exclude other elements or objects. Next, the present invention is described in detail by using schematic diagrams, but these schematic diagrams are only for the convenience of describing the examples of the present invention in detail, and should not be regarded as a limitation of the present invention. As used herein, "proximal" refers to the end close to the heart; "distal" refers to the end close to the operator, that is, the end away from the heart; "axial" refers to the direction parallel to the axis; "radial" refers to the direction perpendicular to the axis; "circumferential" refers to the direction around the axis. As used herein, the "wave rod" refers to the stent rib, and the "wave rod length" refers to the dimension of the stent rib in the extending direction thereof.

<实施例一><Example 1>

如图1所示,本实施例提供一种覆膜支架100,为一体式支架结构,也即,该覆膜支架100并非由多个独立的支架在体内拼接而成,而是在体外便制作形成一个带有分支的支架结构。该覆膜支架100适用于动脉瘤或夹层的病变区域累及血管分叉点及其分支的情况,包括但不限于腹主动脉。以下描述中,主要以病变区域累及腹主动脉及其分支作为示意进行说明,但不构成对本发明的限定。As shown in FIG. 1 , the present embodiment provides a stent-graft 100 with an integrated stent structure, that is, the stent-graft 100 is not formed by splicing a plurality of independent stents in vivo, but is fabricated in vitro A scaffold structure with branches is formed. The stent-graft 100 is suitable for the case where the lesion area of aneurysm or dissection involves the bifurcation point and its branches, including but not limited to the abdominal aorta. In the following description, the abdominal aorta and its branches are mainly involved in the lesion area as a schematic illustration, but it does not constitute a limitation of the present invention.

具体地,所述覆膜支架100包括支架本体,所述支架本体包括主体支架部110和两个分支支架部120,所述覆膜支架100还包括覆膜130。两个分支支架部120和一个主体支架部110都与覆膜130固定连接,从而一体连接成Y形的覆膜支架100。所需理解,支架本体与覆膜可以是一体式结构,也可以是分体式结构,无论是分体还是一体都可以实现支架本体与覆膜之间的固定连接。本文中,两个分支支架部120分别构成同侧的分支支架和对侧的分支支架,且为了便于解释说明,两个分支支架部120定义为第一分支支架部121和第二分支支架部122,第一分支支架部121构成同侧的分支支架,第二分支支架部122构成对侧的分支支架。分支支架部120的外径可以是近端小、远端大,或者分支支架部120的外径不变。Specifically, the stent-graft 100 includes a stent body, and the stent body includes a main stent portion 110 and two branch stent portions 120 , and the stent-graft 100 further includes a membrane 130 . The two branch stent parts 120 and the one main body stent part 110 are both fixedly connected with the covering film 130 , so as to be integrally connected to form a Y-shaped stent covering 100 . It should be understood that the stent body and the covering film may be an integral structure or a separate structure, and a fixed connection between the stent body and the covering film can be achieved regardless of the separate body and the covering film. Herein, the two branch support parts 120 respectively constitute a branch support on the same side and a branch support on the opposite side, and for the convenience of explanation, the two branch support parts 120 are defined as a first branch support part 121 and a second branch support part 122 , the first branch support part 121 constitutes a branch support on the same side, and the second branch support part 122 constitutes a branch support on the opposite side. The outer diameter of the branch stent part 120 may be small at the proximal end and large at the distal end, or the outer diameter of the branch stent part 120 may remain unchanged.

主体支架部110和分支支架部120都为中空的管状结构,主体支架部110的内腔与两个分支支架部120的内腔连通。主体支架部110和分支支架部120都包括若干轴向依次间隔排布的环形支架段(简称支架段),环形支架段为波浪形结构,且环形支架段之间通过覆膜130柔性连接,或者支架段之间除加强筋105外仅通过覆膜130柔性连接。此处“柔性连接”可以理解为环形支架段都仅与覆膜130固定连接,而在轴向方向上任意相邻两个环形支架段之间没有刚性连接件进行连接。如图1所示,在优选情况下,环形支架段之间除加强筋105外无刚性连接,也即,环形支架段之间仅通过覆膜130连接,而覆膜130较为柔软可实现柔性连接。所应理解,“刚性连接”是指当覆膜支架产生位移或受力时,覆膜支架中的环形支架段之间不产生相对位移或变形;“柔性连接”是指覆膜支架产生位移或受力时,覆膜支架中的环形支架段之间可产生相对位移或变形,此时,柔顺性好。Both the main body bracket part 110 and the branch bracket part 120 are hollow tubular structures, and the inner cavity of the main body bracket part 110 communicates with the inner cavity of the two branch bracket parts 120 . The main body support portion 110 and the branch support portion 120 both include a plurality of annular support segments (referred to as support segments) that are arranged in sequence in the axial direction, the annular support segments are of a wave-shaped structure, and the annular support segments are flexibly connected by a covering film 130, or Except for the reinforcing ribs 105 , the stent segments are only flexibly connected by the covering film 130 . Here, "flexible connection" can be understood as the annular stent segments are only fixedly connected with the covering film 130, and there is no rigid connection between any two adjacent annular stent segments in the axial direction. As shown in FIG. 1 , in a preferred case, there is no rigid connection between the annular stent segments except for the reinforcing ribs 105 , that is, the annular stent segments are only connected by the covering film 130 , and the covering film 130 is relatively soft to realize a flexible connection . It should be understood that "rigid connection" means that when the stent-graft is displaced or subjected to force, there is no relative displacement or deformation between the annular stent segments in the stent-graft; "flexible connection" means that the stent-graft produces displacement or deformation. When subjected to force, relative displacement or deformation may occur between the annular stent segments in the covered stent, and at this time, the flexibility is good.

本申请对环形支架段上的波形形状不作限制,可以是锯齿形或弧形或其他合适形状。本申请对制作支架本体的金属材料不作特别的限制,只要是生物相容性好的医用金属材料即可,如316不锈钢、钴铬合金或镍钛合金等医用金属材料。覆膜130为生物相容性好的高分子软性材料,可使支架本体在轴向上形成封闭的内腔,覆膜130可以设置在支架本体的内表面或外表面。The present application does not limit the shape of the waveform on the annular support segment, which can be a zigzag shape or an arc shape or other suitable shapes. The application does not specifically limit the metal material for making the stent body, as long as it is a medical metal material with good biocompatibility, such as 316 stainless steel, cobalt-chromium alloy or nickel-titanium alloy and other medical metal materials. The covering film 130 is a polymer soft material with good biocompatibility, which enables the stent body to form a closed cavity in the axial direction, and the covering film 130 can be arranged on the inner surface or the outer surface of the stent body.

与现有技术相比,本发明的覆膜支架100不但避免了多个独立支架在体内进行拼接所引起的内漏风险,而且缩短了手术时间,极大降低了手术成本。尤其主体支架部110的远端以“骑跨”的方式定位在腹主动脉血管分叉点上,这种固定方式符合人体血管的自然走向,覆膜支架100的分叉点不会发生移位,可有效的降低覆膜支架移位的风险。此外,该覆膜支架100与整体编织的支架结构不同,波浪形的环形支架段具有更小的压握尺寸,这意味着更小的导入路径,对患者的损伤小。而且波浪形的环形支架段之间无刚性连接或除加强筋外无刚性连接,相比于整体编织结构,增加了支架的柔顺性,能更好的与人体迂曲的血管进行匹配,治疗效果更好。Compared with the prior art, the stent-graft 100 of the present invention not only avoids the risk of endoleak caused by splicing multiple independent stents in the body, but also shortens the operation time and greatly reduces the operation cost. In particular, the distal end of the main body stent portion 110 is positioned on the bifurcation point of the abdominal aorta in a "riding" manner. This fixing method conforms to the natural trend of human blood vessels, and the bifurcation point of the stent graft 100 will not be displaced. , which can effectively reduce the risk of stent graft displacement. In addition, the stent-graft 100 is different from the overall braided stent structure, and the wave-shaped annular stent segment has a smaller crimping size, which means a smaller introduction path and less damage to the patient. Moreover, there is no rigid connection between the wave-shaped annular stent segments or no rigid connection except for the reinforcing ribs. Compared with the overall braided structure, the flexibility of the stent is increased, which can better match the tortuous blood vessels of the human body, and the therapeutic effect is better. it is good.

继续参考图1,主体支架部110优选包括从近端至远端依次排布的裸段101、近端密封区102和主体区103,都与覆膜130固定连接,如与覆膜130缝合和/热熔固定连接。具体地,所述环形支架段包括裸段101、近端密封支架段a2和主体支架段a3;所述裸段101也可以理解为包括一个环形支架段;所述近端密封区102包括若干近端密封支架段a2,具体数量不作限定;所述主体区103包括若干主体支架段a3,具体数量亦不限定。应理解,裸段101上不覆盖覆膜130,近端密封区102和主体区103上都设置有覆膜130。还需理解,所述环形支架段还包括分支支架段,且每个所述分支支架部包括分支支架段。Continuing to refer to FIG. 1 , the main body stent portion 110 preferably includes a bare segment 101 , a proximal sealing area 102 and a main body area 103 arranged in sequence from the proximal end to the distal end, all of which are fixedly connected to the covering film 130 , such as suturing and suturing with the covering film 130 . / Hot melt fixed connection. Specifically, the annular stent segment includes a bare segment 101, a proximal sealing stent segment a2 and a main body stent segment a3; the bare segment 101 can also be understood to include an annular stent segment; the proximal sealing region 102 includes several proximal stent segments The specific number of the end sealing bracket segments a2 is not limited; the main body region 103 includes several main body bracket segments a3, and the specific number is also not limited. It should be understood that the coating film 130 is not covered on the bare segment 101 , and the coating film 130 is provided on both the proximal sealing region 102 and the main body region 103 . It should also be understood that the annular support segment further includes a branch support segment, and each of the branch support portions includes a branch support segment.

如图2所示,可通过切割工艺制成裸段101,该裸段101即为一个波浪形的环形支架段,裸段101的远端与覆膜130固定连接,裸段101的近端轴向上伸出覆膜130。裸段101被配置为扩张后与血管壁贴合进行锚定,从而可以延长主体支架部110近端的锚定区,而且裸段101无倒钩,可以既在近端锚定支架,又不损伤血管。优选的,裸段101上设置有后释放结构,用于与输送器配合以实现覆膜支架的后释放。后释放可有效的减少支架释放过程中的前跳与后跳,使释放位置更加精确,治疗效果更好。本申请对后释放的方式不加限制。在一实施例中,如图2所示,所述后释放结构包括孔洞结构1011,裸段101的至少部分波峰上设置孔洞结构1011,该孔洞结构1011用于与输送器匹配,以实现覆膜支架的后释放。As shown in FIG. 2 , a bare segment 101 can be made by a cutting process. The bare segment 101 is a wavy annular stent segment. The distal end of the bare segment 101 is fixedly connected to the covering film 130 . The cover film 130 protrudes upward. The bare segment 101 is configured to adhere to the vessel wall for anchoring after expansion, so that the anchoring area at the proximal end of the stent portion 110 of the main body can be extended, and the bare segment 101 has no barbs, so that the stent can be anchored at the proximal end without being damaged. damage blood vessels. Preferably, the bare segment 101 is provided with a post-release structure for cooperating with the delivery device to realize post-release of the stent graft. The post-release can effectively reduce the forward and backward jumps during the stent release process, so that the release position is more precise and the treatment effect is better. This application does not limit the manner of post-release. In one embodiment, as shown in FIG. 2 , the post-release structure includes a hole structure 1011 , and a hole structure 1011 is provided on at least part of the crest of the bare section 101 , and the hole structure 1011 is used for matching with the conveyor to realize film coating Rear release of the stand.

优选的,裸段101上设置有显影部件(未图示),所述显影部件由金属显影材料制成,以便根据显影部件在X射线下的显影性辨别覆膜支架100的位置和形态。进一步的,裸段101的波杆1012上设置有凹槽结构,所述凹槽结构用于固定显影部件。所述凹槽结构可包括若干第一凹槽结构1013和若干第二凹槽结构1014,第一凹槽结构1013可以固定第一显影部件,第二凹槽结构1014可以固定第二显影部件。第一凹槽结构1013和第二凹槽结构1014设置在裸段101的波杆1012的表面上,且第一凹槽结构1013和第二凹槽结构1014设置在裸段101的不同的波杆1012上。优选的,裸段101的波杆1012的表面凸起,从而在凸起之间形成凹槽结构,从而保证裸段101的强度。所述第一凹槽结构1013的长度大于第二凹槽结构1014的长度,因此,第一显影部件的长度大于第二显影部件的长度。应理解,所述凹槽结构的长度即为沿波杆1012的延伸方向的尺寸。优选的,第一凹槽结构1013的下边缘与第二凹槽结构1014的下边缘平齐,确保显影部件的下边缘与覆膜130的边缘重合,更方便识别覆膜支架近端的位置及形态。所述凹槽结构的下边缘指的是凹槽结构的远端边缘。可选的,第二凹槽结构1014的长度可为1mm~3mm,第一凹槽结构1013的长度可为2mm~6mm。进一步的,第一凹槽结构1013的长度为第二凹槽结构1014的长度的1.5倍~3倍,保证支架覆膜近端的位置及形态可在X射线下被识别。本实施例中,在支架的对侧设置了第一凹槽结构1013来固定第一显影部件,其他方位根据需求设置了第二凹槽结构1014来固定第二显影部件,以用于在X射线下识别支架方向及形态。Preferably, a developing member (not shown) is provided on the bare segment 101, and the developing member is made of a metal developing material, so as to identify the position and shape of the stent graft 100 according to the developing performance of the developing member under X-ray. Further, the wave bar 1012 of the bare segment 101 is provided with a groove structure, and the groove structure is used for fixing the developing component. The groove structure may include several first groove structures 1013 and several second groove structures 1014, the first groove structures 1013 may fix the first developing member, and the second groove structures 1014 may fix the second developing member. The first groove structure 1013 and the second groove structure 1014 are arranged on the surface of the wave rod 1012 of the bare section 101 , and the first groove structure 1013 and the second groove structure 1014 are arranged on different wave rods of the bare section 101 1012 on. Preferably, the surface of the wave rod 1012 of the bare segment 101 is convex, so that a groove structure is formed between the projections, thereby ensuring the strength of the bare segment 101 . The length of the first groove structure 1013 is greater than the length of the second groove structure 1014, therefore, the length of the first developing member is greater than the length of the second developing member. It should be understood that the length of the groove structure is the dimension along the extending direction of the wave rod 1012 . Preferably, the lower edge of the first groove structure 1013 is flush with the lower edge of the second groove structure 1014, so as to ensure that the lower edge of the developing component and the edge of the covering film 130 overlap, which is more convenient to identify the position and location of the proximal end of the stent graft. form. The lower edge of the groove structure refers to the distal edge of the groove structure. Optionally, the length of the second groove structure 1014 may be 1 mm˜3 mm, and the length of the first groove structure 1013 may be 2 mm˜6 mm. Further, the length of the first groove structure 1013 is 1.5 to 3 times the length of the second groove structure 1014, which ensures that the position and shape of the proximal end of the stent covering can be identified under X-rays. In this embodiment, a first groove structure 1013 is set on the opposite side of the bracket to fix the first developing member, and a second groove structure 1014 is set in other directions according to requirements to fix the second developing member, so as to be used in X-ray Identify the orientation and shape of the stent.

请参考图1,近端密封区102包括至少一个变高近端密封支架段1021和至少一个等高近端密封支架段1022。变高近端密封支架段1021中的波谷的深度不相同,且至少一个变高近端密封支架段1021中的任意相邻两个矮波谷之间设置至少一个高波谷。等高近端密封支架段1022中的波谷的深度都相同。“波谷的深度”是指相邻波峰到波谷之间的垂直距离。至少一个变高近端密封支架段1021设置在近端密封区102的最近端。近端密封区102中的等高密封支架段1022的数量不限定,可以是一个或多个。同理,变高近端密封支架段1021的数量可以是一个或多个。至少一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在主体支架部110的轴向上间隔排列,且在主体支架部110的周向上对齐布置。Referring to FIG. 1 , the proximal sealing region 102 includes at least one elevated proximal sealing stent segment 1021 and at least one equal-height proximal sealing stent segment 1022 . The depths of the troughs in the heightened proximal sealing stent segment 1021 are different, and at least one high trough is disposed between any two adjacent short troughs in the at least one heightened proximal sealing stent segment 1021 . The depths of the troughs in the iso-height proximal seal stent segments 1022 are all the same. "Depth of trough" refers to the vertical distance between adjacent peaks to troughs. At least one raised proximal sealing stent segment 1021 is disposed at the proximal-most end of the proximal sealing region 102 . The number of iso-height sealing stent segments 1022 in the proximal sealing region 102 is not limited, and can be one or more. Similarly, the number of the heightened proximal sealing stent segments 1021 may be one or more. At least one heightened proximal sealing stent segment 1021 and at least one equal-height proximal sealing stent segment 1022 are spaced apart in the axial direction of the main body bracket portion 110 and aligned in the circumferential direction of the main body bracket portion 110 .

在图1示出的实施例中,变高近端密封支架段1021的数量为1个,等高近端密封支架段1022的数量为3个,一个变高近端密封支架段1021和三个等高密封支架段1022依次由近端至远端沿主体支架部110的轴向间隔排布,且变高近端密封支架段1021和等高密封支架段1022在主体支架部110的周向上对齐布置。此处,“对齐”是指,如图1所示,在平行于主体支架部的轴线的投影平面上,变高近端密封支架段1021的波峰的投影与等高密封支架段1022的波峰的投影的连线平行于主体支架部的轴线,同样的,变高近端密封支架段1021的波谷的投影与等高密封支架段1022的波谷的投影的连线平行于主体支架部的轴线。应理解,采用变高和等高两种高度的支架段的组合设置,可使覆膜支架100的近端与血管贴合更加紧密,从而有效防止由覆膜支架100的近端与血管贴合不紧所产生的Ia型内漏。In the embodiment shown in FIG. 1 , the number of heightened proximal sealing stent segments 1021 is 1, the number of equal-height proximal sealing stent segments 1022 is 3, one heightened proximal sealing stent segment 1021 and three The contour sealing stent segments 1022 are sequentially spaced from the proximal end to the distal end along the axial direction of the main body stent part 110 , and the heightened proximal sealing stent segments 1021 and the contour sealing stent segments 1022 are aligned in the circumferential direction of the main body stent part 110 layout. Here, "alignment" means, as shown in FIG. 1 , on a projection plane parallel to the axis of the main body stent portion, the projection of the peak of the heightened proximal sealing stent segment 1021 and the peak of the sealing stent segment 1022 of equal height The line connecting the projections is parallel to the axis of the main body support part, and similarly, the line connecting the projection of the trough of the heightened proximal seal support segment 1021 and the projection of the trough of the equal height seal support segment 1022 is parallel to the axis of the body support part. It should be understood that by adopting a combination of two heights of stent segments, the heightened and the same height, the proximal end of the stent-graft 100 can be more closely attached to the blood vessel, thereby effectively preventing the proximal end of the stent-graft 100 from being attached to the blood vessel. Type Ia endoleaks produced by not tightening.

此外,近端密封支架段a2的波杆的最大长度小于主体支架段a3中的波杆长度,例如近端密封支架段a2的波杆长度为4mm~14mm,主体支架段a3中的波杆长度为16mm~24mm。因此,近端密封区102相比于主体区103的波形更为密集,与血管的贴合效果更好。In addition, the maximum length of the wave rod of the proximal sealing stent segment a2 is smaller than that of the main body stent segment a3. For example, the wave rod length of the proximal sealing stent segment a2 is 4 mm to 14 mm, and the wave rod length of the main body stent 16mm to 24mm. Therefore, the waveform of the proximal sealing region 102 is denser than that of the main body region 103, and the fitting effect with the blood vessel is better.

继续参考图1,主体区103包括若干轴向依次排布的主体支架段a3,主体支架段a3的数量根据病变区域的长度进行设置。组成主体区103的主体支架段a3的波峰的高度相同。主体区103的作用是支撑血流通道,使覆膜支架100贴壁。近端密封区102和主体区103都大体为圆柱形状,两者的外径相同。Continuing to refer to FIG. 1 , the main body area 103 includes a plurality of main body stent segments a3 arranged in sequence in the axial direction, and the number of the main body stent segments a3 is set according to the length of the lesion area. The heights of the wave crests of the main body support sections a3 constituting the main body region 103 are the same. The function of the main body region 103 is to support the blood flow channel and make the stent graft 100 adhere to the wall. Both the proximal sealing region 102 and the body region 103 are generally cylindrical in shape with the same outer diameter.

主体支架部110优选还包括过渡区104,所述裸段101、近端密封区102、主体区103和过渡区104从近端至远端依次排布,从而在主体区103和分支支架部120之间设置有过渡区104。过渡区104的外径从近端至远端依次减小,所述过渡区104的近端的外径与主体区103的外径相同,所述主体区103具有相同的外径。此外,所述环形支架段还包括过渡支架段a4,所述过渡区104包括若干过渡支架段a4。优选的,主体区103的横截面形状为圆形;优选的,过渡区104的近端的横截面形状为圆形,过渡区104的远端的横截面形状为椭圆形,椭圆形的长轴和短轴都依次减小。组成过渡区104的过渡支架段a4的数量不做限制,包括但不限于一个过渡支架段a4,通常为一个过渡支架段a4即可。因此,在优选情况下,主体支架部110的近端横截面为圆形,远端横截面为椭圆形。过渡区104的作用在于使主体支架部110与两个分支支架部120过渡平滑,以符合人体血管解剖构造,贴合效果好。此外,过渡区104采用了变径结构,能够与覆膜130的变径段贴合的更好,也更符合人体血管直径自然变化趋势。故相比于传统的等径结构,过渡区104的设置,可以使覆膜支架具有更好的内腔保持性,有效避免了支架的分支随着血管迂曲而产生闭塞的问题。The main body stent part 110 preferably further includes a transition area 104 , and the bare section 101 , the proximal end sealing area 102 , the main body area 103 and the transition area 104 are sequentially arranged from the proximal end to the distal end, so that the main body area 103 and the branch stent part 120 are arranged in sequence from the proximal end to the distal end. A transition area 104 is provided in between. The outer diameter of the transition region 104 decreases sequentially from the proximal end to the distal end, and the outer diameter of the proximal end of the transition region 104 is the same as the outer diameter of the main body region 103 , and the main body region 103 has the same outer diameter. In addition, the annular support segment further includes a transition support segment a4, and the transition region 104 includes several transition support segments a4. Preferably, the cross-sectional shape of the main body region 103 is circular; preferably, the cross-sectional shape of the proximal end of the transition region 104 is circular, and the cross-sectional shape of the distal end of the transition region 104 is elliptical, and the long axis of the ellipse is elliptical. and the short axis decrease in turn. The number of the transition support sections a4 forming the transition area 104 is not limited, including but not limited to one transition support section a4, usually one transition support section a4 is sufficient. Therefore, in a preferred case, the proximal cross-section of the main body stent portion 110 is circular, and the distal cross-section is oval. The function of the transition area 104 is to make the transition between the main body support part 110 and the two branch support parts 120 smooth, so as to conform to the anatomical structure of human blood vessels, and the fitting effect is good. In addition, the transition area 104 adopts a variable diameter structure, which can better fit with the variable diameter section of the covering film 130, and is also more in line with the natural change trend of the diameter of the blood vessels of the human body. Therefore, compared with the traditional equal-diameter structure, the provision of the transition region 104 can make the stent-graft have better lumen retention, and effectively avoid the problem of occlusion of the branches of the stent along with the tortuosity of the blood vessel.

所述覆膜支架100优选还包括加强筋105,与覆膜130固定连接,所述加强筋105被配置用于限制主体支架部110在轴向上的回缩。使用加强筋105后,在尽可能保留覆膜支架100的柔顺性能的基础上,可有效防止覆膜支架100轴向短缩,有效降低覆膜支架100的近端移位的风险。优选的,所述加强筋105的材料为生物形容性好的金属材料,包括且不限于镍钛、钴铬合金或316不锈钢。The stent-graft 100 preferably further includes a reinforcing rib 105 fixedly connected to the covering film 130, and the reinforcing rib 105 is configured to limit the retraction of the main body stent portion 110 in the axial direction. After the reinforcing ribs 105 are used, on the basis of retaining the compliance performance of the stent graft 100 as much as possible, the axial shortening of the stent graft 100 can be effectively prevented, and the risk of proximal displacement of the stent graft 100 can be effectively reduced. Preferably, the material of the reinforcing rib 105 is a metal material with good biodescription, including but not limited to nickel titanium, cobalt chromium alloy or 316 stainless steel.

请参考图3,并结合图1,加强筋105为细长的杆状结构并沿主体支架部110的轴向延伸设置,且加强筋105的近端和远端均与覆膜130固定连接,如缝合和/或热熔连接。其中加强筋105的近端设置在主体区103上,远端设置在过渡区104的近端,以限制主体区103的轴向缩短。此处,应理解,加强筋105实际与覆膜130固定连接,但加强筋105与覆膜130的固定位置需要确保加强筋105的远端在过渡区104的近端,加强筋105的近端在主体区103上。优选的,加强筋105的近端设置于主体区103的近端的第一个主体支架段a3上,如固定在主体区103的近端的第一个主体支架段a3的波峰、波谷或波峰与波谷之间的位置。Please refer to FIG. 3 , in conjunction with FIG. 1 , the reinforcing rib 105 is an elongated rod-shaped structure extending along the axial direction of the main body support portion 110 , and the proximal end and the distal end of the reinforcing rib 105 are fixedly connected to the covering film 130 , Such as stitching and/or hot melt joining. The proximal end of the reinforcing rib 105 is arranged on the main body region 103 , and the distal end is arranged at the proximal end of the transition region 104 to limit the axial shortening of the main body region 103 . Here, it should be understood that the reinforcing rib 105 is actually fixedly connected to the film 130, but the fixed position of the reinforcing rib 105 and the film 130 needs to ensure that the distal end of the reinforcing rib 105 is at the proximal end of the transition area 104, and the proximal end of the reinforcing rib 105 on the main body area 103 . Preferably, the proximal end of the reinforcing rib 105 is disposed on the first main body support section a3 at the proximal end of the main body area 103 , such as a crest, a wave trough or a wave crest of the first main body support section a3 at the proximal end of the main body area 103 . and the position between the troughs.

加强筋105的数量优选为一根,以确保覆膜支架的柔顺性。优选的,加强筋105的远端设置于过渡区104的近端的第一个过渡支架段a4上,更优选,加强筋105的远端设置在过渡区104的近端的第一个过渡支架段a4的波峰上。本申请对加强筋105的长度不作特别的限定,具体根据主体支架部110的规格来确定加强筋105的长度。例如在一具体的实施例中,加强筋105的长度为主体区103的轴向长度的1%~80%。The number of reinforcing ribs 105 is preferably one to ensure the flexibility of the stent graft. Preferably, the distal end of the reinforcing rib 105 is arranged on the first transition bracket section a4 at the proximal end of the transition area 104 , and more preferably, the distal end of the reinforcing rib 105 is arranged on the first transition bracket at the proximal end of the transition area 104 . on the crest of segment a4. The present application does not specifically limit the length of the reinforcing rib 105 , and specifically determines the length of the reinforcing rib 105 according to the specification of the main body bracket portion 110 . For example, in a specific embodiment, the length of the reinforcing rib 105 is 1% to 80% of the axial length of the main body region 103 .

进一步的,如图3所示,加强筋105的两端可设置固定孔1051,所述加强筋105通过两端的固定孔1051与覆膜130缝合连接和/或热熔连接。固定孔1051的设置,可保证加强筋105的两端与覆膜130固定牢靠,不易滑脱。覆膜支架100的定位方式为支架分叉点“骑跨”在腹主动脉分叉点,配合加强筋105,可有效防止覆膜支架在迂曲的腹主动脉中发生短缩,确保定位的精确性。还应理解,本文中,环形支架段朝向近端凸起的为“波峰”,反之为“波谷”。Further, as shown in FIG. 3 , both ends of the reinforcing rib 105 may be provided with fixing holes 1051 , and the reinforcing rib 105 is sewed and/or thermally connected to the film 130 through the fixing holes 1051 at both ends. The setting of the fixing holes 1051 can ensure that the two ends of the reinforcing rib 105 are firmly fixed to the covering film 130 and are not easily slipped off. The positioning method of the stent-graft 100 is that the stent bifurcation point "rides" on the bifurcation point of the abdominal aorta, and with the reinforcing ribs 105, it can effectively prevent the stent-graft from shortening in the tortuous abdominal aorta and ensure accurate positioning. sex. It should also be understood that, herein, the annular stent segments that bulge toward the proximal end are referred to as "peaks", and vice versa.

返回参考图1,所述覆膜支架100优选还包括牙线140,由PTFE、PET或超高分子聚乙烯等具有良好生物相容性的软性高分子材料制成。牙线140的近端与覆膜130固定连接,并用于绑扎主体支架部110的每个环形支架段,以减小支架的尺寸,便于在体内进行支架的位置调整。Referring back to FIG. 1 , the stent-graft 100 preferably further includes a dental floss 140, which is made of a soft polymer material with good biocompatibility such as PTFE, PET, or ultra-high molecular weight polyethylene. The proximal end of the dental floss 140 is fixedly connected to the membrane 130 and is used to bind each annular bracket segment of the main body bracket portion 110 to reduce the size of the bracket and facilitate the position adjustment of the bracket in vivo.

请参考图1,将牙线140进行打结,在打结处形成若干主体束缚线圈141。主体束缚线圈141的数量和位置与需要绑扎的主体支架部110上的环形支架段的数量和位置一一对应。绑扎时,如图4所示,优选主体束缚线圈141穿过支架段上对应位置的束缚线圈106,可将主体支架部110的直径束缚最小,约为支架名义直径的10%~20%。其中束缚线圈106起到对主体束缚线圈141限位的作用,绑扎更为可靠和牢固。束缚线圈106的数量和位置可根据需求进行设置。这种绑扎结构可靠且强度高。束缚线圈106的结构不作限定,可以是在支架上额外缝合形成束缚线圈106。Referring to FIG. 1 , the dental floss 140 is knotted, and a plurality of main body binding coils 141 are formed at the knots. The number and positions of the main body binding coils 141 correspond to the number and positions of the annular bracket segments on the main body bracket portion 110 to be bound in a one-to-one manner. When tying, as shown in FIG. 4 , preferably the main body restraining coil 141 passes through the restraining coil 106 at the corresponding position on the stent segment, which can restrain the diameter of the main body stent portion 110 to a minimum, about 10%-20% of the nominal diameter of the stent. The binding coil 106 plays a role in limiting the position of the binding coil 141 of the main body, and the binding is more reliable and firm. The number and location of the restraint coils 106 can be set as desired. This binding structure is reliable and high strength. The structure of the restraint coil 106 is not limited, and the restraint coil 106 may be formed by additional suturing on the stent.

参考图1,所述覆膜支架100还可包括分支束缚线圈150,由PTFE、PET或超高分子聚乙烯等具有良好生物相容性的软性高分子材料制成。可选的,所述分支束缚线圈150为蝴蝶型线圈,即“8”字形线圈。其中,第一分支支架部121的每个环形支架段上设置至少2个分支束缚线圈150,且每个环形支架段的至少2个分支束缚线圈150优选固定在该支架段的同一圆周方向上,至少2个分支束缚线圈150分别从两侧环抱支架段。由于采用翻山的手术方式,使得对侧的第二分支支架部122无需绑扎分支束缚线圈150。此处的“翻山”的手术方式为本领域的公知技术,即可以理解为,腹主动脉与双侧髂动脉为倒Y字型结构,翻山即为从一侧髂动脉采用导丝导管等耗材建立双侧髂动脉的通路,形似翻山。Referring to FIG. 1 , the stent-graft 100 may further include a branched confinement coil 150, which is made of a soft polymer material with good biocompatibility, such as PTFE, PET, or ultra-high molecular weight polyethylene. Optionally, the branch binding coil 150 is a butterfly-shaped coil, that is, an "8"-shaped coil. Wherein, each annular support segment of the first branch support portion 121 is provided with at least two branch restraint coils 150, and at least two branch restraint coils 150 of each ring support segment are preferably fixed in the same circumferential direction of the support segment, At least two branch restraint coils 150 respectively surround the stent segment from both sides. Due to the use of a mountain-turning operation, the second branch support portion 122 on the opposite side does not need to bind the branch restraint coil 150 . The operation method of "climbing the mountain" here is a well-known technique in the art, that is, it can be understood that the abdominal aorta and the bilateral iliac arteries are in an inverted Y-shaped structure, and the iliac artery on one side is using a guide wire catheter to climb the mountain. Consumables are used to establish bilateral iliac artery access, which is like turning over a mountain.

请参考图5,分支束缚线圈150采用两侧环绕对第一分支支架部121进行绑扎的方式,即2个从同一点出发的分支束缚线圈150从两侧将第一分支支架部121“抱住”,以达到绑扎束缚的效果。该结构简单,易操作,绑扎效果牢靠。采用这种绑扎结构,拉动束缚导丝,即可实现第一分支支架部121的释放,可有效避免释放时线结点被卡住导致的支架无法弹开。同样地,分支束缚线圈150可以配合第一分支支架部121的支架段上的束缚线圈106(图5未示出)使用,束缚线圈106起到对分支束缚线圈150限位的作用,绑扎更可靠。Please refer to FIG. 5 , the branch restraint coil 150 adopts the method of wrapping the first branch support part 121 on both sides, that is, two branch restraint coils 150 starting from the same point hug the first branch support part 121 ″ from both sides ”, in order to achieve the effect of binding and restraint. The structure is simple, the operation is easy, and the binding effect is reliable. By adopting this binding structure, the first branch support portion 121 can be released by pulling the binding guide wire, which can effectively avoid the failure of the support to pop open due to the wire node being stuck during release. Similarly, the branch restraint coil 150 can be used in conjunction with the restraint coil 106 (not shown in FIG. 5 ) on the bracket section of the first branch support part 121 , and the restraint coil 106 plays a role in limiting the position of the branch restraint coil 150 , and the binding is more reliable .

人的血管尺寸及分布特征个体差异性较大,为此,覆膜支架100的尺寸可按照患者的血管尺寸进行选择。在一示意性实施例中,如图1所示,主体支架部110的长度L1为30mm~130mm,主体支架部110的直径D1为16mm~34mm,第一分支支架部121的长度L2为20mm~80mm,第二分支支架部122的长度L3为20mm~80mm,第一分支支架部121的直径D2为8mm~24mm,第二分支支架部122的直径D3为8mm~24mm。与传统覆膜支架不同的是,当患者髂动脉病变处血管直径很大时,仍然可根据患者的特殊情况调整分支支架部120的大小,最终做成一体式覆膜支架100。即两分支支架部120的直径之和可大于主体支架部110的直径,当然也可小于或等于主体支架部110的直径。The size and distribution characteristics of human blood vessels vary greatly among individuals. Therefore, the size of the stent graft 100 can be selected according to the size of the blood vessels of the patient. In an exemplary embodiment, as shown in FIG. 1 , the length L1 of the main body bracket portion 110 is 30 mm˜130 mm, the diameter D1 of the main body bracket portion 110 is 16 mm˜34 mm, and the length L2 of the first branch bracket portion 121 is 20 mm˜20 mm. 80 mm, the length L3 of the second branch support part 122 is 20 mm to 80 mm, the diameter D2 of the first branch support part 121 is 8 mm to 24 mm, and the diameter D3 of the second branch support part 122 is 8 mm to 24 mm. Different from the traditional stent-graft, when the patient's iliac artery lesion has a large blood vessel diameter, the size of the branch stent portion 120 can still be adjusted according to the patient's special condition, and finally an integrated stent-graft 100 is made. That is, the sum of the diameters of the two branch support parts 120 may be greater than the diameter of the main body support part 110 , and certainly may be smaller than or equal to the diameter of the main body support part 110 .

<实施例二><Example 2>

请参考图6、图7a、图7b和图7c,在本发明的另一个实施例中,还提供了一种覆膜支架100’,该覆膜支架100’取消了裸段,而在主体支架部110的近端直接配置近端密封区102’,也即,本实施例的覆膜支架100’的主体支架部110包括从近端至远端依次排布的近端密封区102’、主体区103和过渡区104。另外的不同是,该近端密封区102’中的变高近端密封支架段121和等高近端密封支架段122的相对位置有所调整。Please refer to FIG. 6 , FIG. 7 a , FIG. 7 b and FIG. 7 c , in another embodiment of the present invention, a stent-graft 100 ′ is also provided. The stent-graft 100 ′ cancels the bare segment, while the main stent The proximal end of the portion 110 is directly configured with the proximal sealing region 102', that is, the main body stent portion 110 of the stent-graft 100' of this embodiment includes the proximal sealing region 102', the main body and the zone 103 and transition zone 104. Another difference is that the relative positions of the heightened proximal sealing stent segment 121 and the equal-height proximal sealing stent segment 122 in the proximal sealing region 102' are adjusted.

具体地,在本实施例中,近端密封区102’包括一个变高近端密封支架段1021和至少一个等高近端密封支架段1022。将一个变高近端密封支架段1021和最近端的一个等高近端密封支架段1022在主体支架部110的轴向上重叠排列,且在主体支架部110的周向上错开布置,从而在近端密封区102的最近端形成一个变高和等高交叠设置的支架段。交叠后形成的环形支架段中任意相邻两个矮波峰之间设置至少一个高波峰。其中高波峰的下顶点与矮波峰的下顶点对齐并在同一圆周上。因此,交叠后形成的环形支架段的下顶点对齐,上顶点呈现高矮变化。还应理解,所述“轴向上重叠”指的是,一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在同一圆周方向上;“周向上错开布置”指的是,一个变高近端密封支架段1021和至少一个等高近端密封支架段1022在同一圆周方向上的波峰之间错开而不重叠,具体见图7c。该方案中,至少一个变高近端密封支架段1021设置在近端密封区102’的最近端,至少一个变高近端密封支架段1021中的任意相邻两个矮波峰间设置至少一个高波峰。Specifically, in the present embodiment, the proximal sealing region 102' includes one proximal sealing stent segment 1021 with heightened height and at least one proximal sealing stent segment 1022 of equal height. A heightened proximal sealing stent segment 1021 and a proximal sealing stent segment 1022 of the same height at the proximal end are overlapped and arranged in the axial direction of the main body bracket portion 110, and are arranged staggered in the circumferential direction of the main body bracket portion 110, so that the proximal end The proximal-most end of the sealing region 102 forms a stent segment that overlaps with heightened and equal heights. At least one high wave crest is set between any two adjacent short wave crests in the annular support segments formed by overlapping. Wherein the lower apex of the taller crest is aligned and on the same circumference as the lower apex of the short crest. Therefore, the lower vertices of the ring-shaped stent segments formed after overlapping are aligned, and the upper vertices exhibit height changes. It should also be understood that the "overlapping in the axial direction" refers to that a heightened proximal sealing stent segment 1021 and at least one proximal sealing stent segment 1022 of equal height are in the same circumferential direction; "circumferentially staggered arrangement" refers to Yes, one variable-height proximal sealing stent segment 1021 and at least one equal-height proximal sealing stent segment 1022 are staggered but not overlapped between the wave crests in the same circumferential direction, see Fig. 7c for details. In this solution, at least one heightened proximal sealing stent segment 1021 is disposed at the proximal end of the proximal sealing region 102', and at least one heightened proximal sealing stent segment 1021 is provided between any two adjacent short wave peaks. crest.

此时,主体支架部110在最近端的变高和等高的交错式结构设计,可使支架近端与血管紧密贴合,可有效防止由支架近端与血管贴合不紧所产生的Ia型内漏,同时也可使支架拥有更好的近端圆整性和更大的径向支撑力,从而可有效地预防由支架近端与血管贴合不严造成的I型内漏,同时近端首段变高的结构设计也可配合后释放使支架释放精准。At this time, the staggered structure design of the height and the same height at the proximal end of the main body stent portion 110 can make the proximal end of the stent closely fit the blood vessel, and can effectively prevent the type Ia caused by the loose fitting between the proximal end of the stent and the blood vessel. At the same time, it can also make the stent have better roundness at the proximal end and greater radial support force, which can effectively prevent the type I endoleak caused by the poor adhesion between the proximal end of the stent and the blood vessel. The structural design of the heightened head section can also be matched with the rear release to make the stent release accurately.

如图6所示,最近端的一个变高近端密封支架段1021的高波峰的近端轴向上伸出覆膜130的部分形成伸出段,此时,伸出段的长度优选为1.5mm~5mm,变高近端密封支架段1021中的高波峰的数量约为3-6个,而且高波峰上可设置孔洞结构来配合输送器实现后释放的功能,可有效的减少支架释放过程中的前跳与后跳,使释放位置更加准确。而且这种结构方便与圆筒状支架(CUFF)配合使用。与普通CUFF配合使用可增加治疗区域的长度。与各种开孔CUFF配合使用时,开孔CUFF可重建近端内脏区分支血管的血流通道。使用方式及尺寸十分灵活。As shown in FIG. 6 , the protruding section is formed by the proximal end of the high crest of the proximal-most heightened proximal sealing stent segment 1021 protruding from the covering film 130 in the axial direction to form a protruding section, at this time, the length of the protruding section is preferably 1.5 mm ~5mm, the number of high peaks in the heightened proximal sealing stent segment 1021 is about 3-6, and a hole structure can be set on the high peak to cooperate with the conveyor to achieve the function of post-release, which can effectively reduce the stent release process. The forward and backward jumps make the release position more accurate. And this structure is convenient to use with the cylindrical support (CUFF). Use with regular CUFF to increase the length of the treatment area. When used in conjunction with various fenestrated CUFFs, fenestrated CUFF can reconstruct the blood flow channels of branch vessels in the proximal visceral region. The usage and size are very flexible.

本实施例所示出的覆膜支架100’的其余结构与实施例一中的覆膜支架100的结构基本相同,对于相同部分,不再详细描述,具体可参阅上述实施例一。The rest of the structure of the stent graft 100' shown in this embodiment is basically the same as the structure of the stent graft 100 in the first embodiment, and the same parts will not be described in detail. For details, refer to the above-mentioned first embodiment.

应理解,本发明的覆膜支架在释放后,覆膜支架的分叉点与人体髂动脉分叉点重合,即支架主体支架部的远端骑跨在髂动脉分叉点上。这种固定方式符合人体血管的自然走向,支架分叉点不会发生移位,尤其配合加强筋时,加强筋远端设置于过渡区近端,有效降低支架短缩和近端移位的风险。同时裸段或伸出段的无倒钩设计一方面避免了倒钩对血管的损伤,另一方面延长了支架近端的锚定区,从而可以拓宽支架的使用范围,也使支架近端可以很好地与血管锚定。此外,近端密封区和过渡区的特殊结构设计可以使主体支架部与血管紧密贴合,极大地降低了Ia型内漏的风险。由于人体腹主动脉远端分叉成为两侧髂动脉,故,本发明的覆膜支架特别适合于腹主动脉,同时本申请的内漏风险和远期移位风险低,有效的弥补了现有覆膜支架所存在的缺点。It should be understood that after the stent-graft of the present invention is released, the bifurcation point of the stent-graft coincides with the bifurcation point of the human iliac artery, that is, the distal end of the stent part of the stent body rides on the bifurcation point of the iliac artery. This fixation method conforms to the natural trend of human blood vessels, and the stent bifurcation point will not be displaced. Especially when the reinforcing ribs are used, the distal end of the reinforcing ribs is set at the proximal end of the transition area, which effectively reduces the risk of stent shortening and proximal displacement. . At the same time, the barb-free design of the bare segment or the extended segment avoids the damage of the barb to the blood vessel on the one hand, and on the other hand extends the anchoring area of the proximal end of the stent, thereby broadening the scope of use of the stent, and also enabling the proximal end of the stent to Well anchored to blood vessels. In addition, the special structural design of the proximal sealing area and the transition area can make the main body stent fit closely with the blood vessel, which greatly reduces the risk of type Ia endoleak. Since the distal end of the human abdominal aorta bifurcates into the iliac arteries on both sides, the stent-graft of the present invention is particularly suitable for the abdominal aorta, and at the same time, the risk of endoleak and long-term displacement of the present application is low, effectively making up for the existing There are disadvantages of stent grafts.

上述描述仅是对本发明较佳实施例的描述,并非对本发明范围的任何限定,本发明领域的普通技术人员根据上述揭示内容做的任何变更、修饰,均属于本发明的保护范围。The above description is only a description of the preferred embodiments of the present invention, and is not intended to limit the scope of the present invention. Any changes and modifications made by those of ordinary skill in the field of the present invention based on the above disclosure all belong to the protection scope of the present invention.

Claims (10)

1. A covered stent is characterized in that the covered stent is of an integrated stent structure and comprises a stent body, reinforcing ribs and a covered membrane; the covering film is arranged on the surface of the stent body; the bracket body comprises a main bracket part and a branch bracket part; the two branch support parts and the main body support part are fixedly connected with the film and integrally connected to form a Y-shaped structure; and the bifurcation point of the stent graft is used for adapting to the vessel bifurcation point so that the stent graft can straddle the vessel bifurcation point;
the bracket body comprises a plurality of annular bracket sections which are sequentially arranged at intervals in the axial direction;
the main body support part comprises a near end sealing area, a main body area and a transition area which are sequentially arranged from a near end to a far end; the body regions have the same outer diameter; the outer diameter of the transition area is sequentially reduced from the near end to the far end; the outer diameter of the proximal end of the transition region is the same as the outer diameter of the body region;
the bracket section comprises a near-end sealing bracket section, a transition bracket section, a main bracket section and a branch bracket section; the proximal sealing zone comprises the proximal sealing stent segment, the transition zone comprises the transition stent segment, and the body zone comprises the body stent segment;
the maximum length of the wave bars of the proximal seal carrier section is less than the length of the wave bars of the main body carrier section.
The number of the reinforcing ribs is one, the reinforcing ribs are fixedly connected with the film, and the reinforcing ribs extend along the axial direction of the main body support part; the near end of strengthening rib set up in on the main part district, the distal end of strengthening rib set up in the near end of transition district, the strengthening rib can restrict main part support portion is upwards retracted in the axial.
2. The stent-graft of claim 1, wherein the length of the ribs is between 1% and 80% of the axial length of the body region.
3. The stent graft of claim 1, wherein the distal ends of said ribs are disposed on the peaks of a first of said transition stent segments proximal to said transition region and/or the proximal ends of said ribs are disposed on a first of said main stent segments proximal to said main body region.
4. The stent-graft of claim 1, wherein the proximal seal zone comprises at least one high proximal seal stent segment and at least one contoured proximal seal stent segment; the at least one high-proximal end sealing support section and the at least one high-proximal end sealing support section are arranged at intervals in the axial direction of the main body support part and are arranged in an aligned mode in the circumferential direction of the main body support part; said at least one heightened proximal seal holder section is disposed at a proximal-most end of said proximal seal zone; at least one high wave trough is arranged between any two adjacent low wave troughs in the at least one high-proximal sealing bracket section.
5. The stent graft of claim 4, wherein the main body stent portion further comprises a bare section, the bare section comprises an annular stent section, the distal end of the bare section is fixedly connected with the stent graft, the proximal end of the bare section axially extends out of the stent graft, the bare section is configured to be expanded and then attached to a vessel wall for anchoring, and a rear release structure is disposed on the bare section for cooperating with a delivery device to effect rear release of the stent graft.
6. The stent graft of claim 5, wherein the bare segment has a groove structure disposed thereon, the groove structure having a development component disposed therein; the groove structure comprises a first groove structure and a second groove structure, the length of the first groove structure is larger than that of the second groove structure, the first groove structure and the second groove structure are arranged on different wave bars of the naked section, and the lower edge of the first groove structure is flush with the lower edge of the second groove structure, so that the lower edge of the developing component is coincident with the near-end edge of the film.
7. The stent graft of claim 6, wherein the length of the first groove structure is between 1.5 and 3 times the length of the second groove structure.
8. The stent graft of claim 1, wherein the cross-sectional shape of the body region is circular, the cross-sectional shape of the proximal end of the transition region is circular, and the cross-sectional shape of the distal end of the transition region is elliptical.
9. The stent-graft of claim 1, further comprising a branch tie coil configured for tying each stent segment of the branch stent portions on the same side, each stent segment of the branch stent portions on the same side being tied by at least two of the branch tie coils.
10. The stent-graft of claim 1, wherein the length of the branch stent part is 20mm to 80mm, and/or the outer diameter of the branch stent part is small at the proximal end and large at the distal end.
CN202210255550.2A 2021-12-08 2021-12-08 stent graft Withdrawn CN114432001A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210255550.2A CN114432001A (en) 2021-12-08 2021-12-08 stent graft

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111487656.7A CN113876467B (en) 2021-12-08 2021-12-08 stent graft
CN202210255550.2A CN114432001A (en) 2021-12-08 2021-12-08 stent graft

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202111487656.7A Division CN113876467B (en) 2021-12-08 2021-12-08 stent graft

Publications (1)

Publication Number Publication Date
CN114432001A true CN114432001A (en) 2022-05-06

Family

ID=79015909

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202111487656.7A Active CN113876467B (en) 2021-12-08 2021-12-08 stent graft
CN202210255550.2A Withdrawn CN114432001A (en) 2021-12-08 2021-12-08 stent graft

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202111487656.7A Active CN113876467B (en) 2021-12-08 2021-12-08 stent graft

Country Status (2)

Country Link
CN (2) CN113876467B (en)
WO (1) WO2023104001A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023104001A1 (en) * 2021-12-08 2023-06-15 上海微创心脉医疗科技(集团)股份有限公司 Covered stent

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116965990A (en) * 2022-04-22 2023-10-31 上海蓝脉医疗科技有限公司 Medical support
CN114652495B (en) * 2022-05-18 2022-08-30 上海微创心脉医疗科技(集团)股份有限公司 Covered stent
CN115381610B (en) * 2022-10-27 2023-01-31 北京华脉泰科医疗器械股份有限公司 High compliance tectorial membrane support
CN117100456B (en) * 2023-10-18 2024-02-02 北京华脉泰科医疗器械股份有限公司 Vascular stent and conveyor thereof
CN117918998A (en) * 2023-12-05 2024-04-26 杭州创心医学科技有限公司 A coated stent
CN117442405B (en) * 2023-12-25 2024-03-22 北京华脉泰科医疗器械股份有限公司 Integrated aortic multi-branch stent and aortic vascular repair assembly

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942691B1 (en) * 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
CN101176686A (en) * 2007-11-20 2008-05-14 微创医疗器械(上海)有限公司 Tectorial bracket
US20110218617A1 (en) * 2010-03-02 2011-09-08 Endologix, Inc. Endoluminal vascular prosthesis
CN102247231A (en) * 2011-03-31 2011-11-23 微创医疗器械(上海)有限公司 Improved intraoperation stent system
US20120150273A1 (en) * 2009-07-31 2012-06-14 Jotec Gmbh One-piece bifurcation graft
US20140058402A1 (en) * 2012-08-27 2014-02-27 Cook Medical Technologies Llc Endoluminal prosthesis and delivery device
CN104586537A (en) * 2013-10-31 2015-05-06 微创心脉医疗科技(上海)有限公司 Covered stent
CN106344209A (en) * 2016-10-11 2017-01-25 有研医疗器械(北京)有限公司 Abdominal aorta covered stent and conveying device thereof and using method
CN107569311A (en) * 2017-07-05 2018-01-12 杭州唯强医疗科技有限公司 Ring holder
CN208229020U (en) * 2017-08-01 2018-12-14 有研医疗器械(北京)有限公司 A kind of branch type film-coated vascular bracket
CN212415985U (en) * 2020-06-30 2021-01-29 上海微创心脉医疗科技股份有限公司 Stent system
WO2021219074A1 (en) * 2020-04-30 2021-11-04 杭州唯强医疗科技有限公司 Covered stent

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2817768Y (en) * 2005-05-24 2006-09-20 微创医疗器械(上海)有限公司 Tectorium stand and host cage section thereof
CN2845771Y (en) * 2005-11-03 2006-12-13 微创医疗器械(上海)有限公司 Artificial blood vessel rack capable of preventing internal leaking
CN101836911A (en) * 2009-03-18 2010-09-22 微创医疗器械(上海)有限公司 Collateral filmed stent
US20130289701A1 (en) * 2012-04-27 2013-10-31 Medtronic Vascular, Inc. Stent-graft prosthesis for placement in the abdominal aorta
AU2013206712B1 (en) * 2013-07-03 2013-11-28 Cook Medical Technologies Llc Endovascular graft having a cannulation pocket
CN105848611B (en) * 2013-12-24 2019-01-29 尼普洛株式会社 bracket
CN104706448B (en) * 2015-03-26 2017-03-08 黄连军 Overlay film frame and overlay film frame induction system
CN105030373A (en) * 2015-09-07 2015-11-11 湖南埃普特医疗器械有限公司 Aorta covered stent
CN205041568U (en) * 2015-09-30 2016-02-24 韩新巍 Sealed mounting system of main common iliac artery tumour intracavity of type of falling Y integration
CN105213074B (en) * 2015-10-21 2017-04-05 湖南埃普特医疗器械有限公司 A kind of overlay film frame and its using method
CA3055567C (en) * 2017-03-08 2021-11-23 W. L. Gore & Associates, Inc. Steering wire attach for angulation
CN107397610A (en) * 2017-08-25 2017-11-28 杭州唯强医疗科技有限公司 Overlay film frame
JP2022500134A (en) * 2018-09-12 2022-01-04 エンドーロジックス リミテッド ライアビリティ カンパニー Stent graft system and method with inflatable filling structure and fillable cuff
CN109350310B (en) * 2018-12-14 2021-07-02 宁波健世科技股份有限公司 Valve stent capable of avoiding coronary artery blockage
CN111067664B (en) * 2019-12-25 2022-07-05 先健科技(深圳)有限公司 Covered stent
CN111437087B (en) * 2020-04-02 2024-03-19 杭州唯强医疗科技有限公司 bifurcated stent
CN112603594B (en) * 2020-12-25 2024-08-20 卢莉茵 Vascular stent graft, vascular stent graft component and vascular stent graft binding method
CN112773585B (en) * 2020-12-30 2023-11-14 杭州唯强医疗科技有限公司 Implantation of stents
CN113876467B (en) * 2021-12-08 2022-04-15 上海微创心脉医疗科技(集团)股份有限公司 stent graft

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942691B1 (en) * 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
CN101176686A (en) * 2007-11-20 2008-05-14 微创医疗器械(上海)有限公司 Tectorial bracket
US20120150273A1 (en) * 2009-07-31 2012-06-14 Jotec Gmbh One-piece bifurcation graft
US20110218617A1 (en) * 2010-03-02 2011-09-08 Endologix, Inc. Endoluminal vascular prosthesis
CN102247231A (en) * 2011-03-31 2011-11-23 微创医疗器械(上海)有限公司 Improved intraoperation stent system
US20140058402A1 (en) * 2012-08-27 2014-02-27 Cook Medical Technologies Llc Endoluminal prosthesis and delivery device
CN104586537A (en) * 2013-10-31 2015-05-06 微创心脉医疗科技(上海)有限公司 Covered stent
CN106344209A (en) * 2016-10-11 2017-01-25 有研医疗器械(北京)有限公司 Abdominal aorta covered stent and conveying device thereof and using method
CN107569311A (en) * 2017-07-05 2018-01-12 杭州唯强医疗科技有限公司 Ring holder
CN208229020U (en) * 2017-08-01 2018-12-14 有研医疗器械(北京)有限公司 A kind of branch type film-coated vascular bracket
WO2021219074A1 (en) * 2020-04-30 2021-11-04 杭州唯强医疗科技有限公司 Covered stent
CN212415985U (en) * 2020-06-30 2021-01-29 上海微创心脉医疗科技股份有限公司 Stent system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023104001A1 (en) * 2021-12-08 2023-06-15 上海微创心脉医疗科技(集团)股份有限公司 Covered stent

Also Published As

Publication number Publication date
CN113876467B (en) 2022-04-15
CN113876467A (en) 2022-01-04
WO2023104001A1 (en) 2023-06-15

Similar Documents

Publication Publication Date Title
CN113876467B (en) stent graft
JP6781203B2 (en) Intraluminal prosthesis with diversionable bifurcation
EP0951253B1 (en) Apparatus for delivering and deploying an endoprosthesis
JP6784490B2 (en) Macrovascular stent graft for debranching and how to use
JP6071244B2 (en) Stent and stent graft
JP2013543416A (en) Stent graft system
CN118490412A (en) Vascular stent, stent system and delivery system
WO2024198794A1 (en) Fenestrated stent, covered stent system, and suturing method for fenestrated stent
CN112842619A (en) Bow covered stent and covered stent conveyor
WO2023221712A1 (en) Covered stent
CN114681113A (en) Covered stent system
CN113081388A (en) Covered stent system and covered stent thereof
CN204364174U (en) The collateral type intravascular stent of iliac artery
CN216136110U (en) Covered stent system
WO2014045428A1 (en) Indwelling device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20220506